First AD

Second AD

Gynecologic Oncology

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Advanced Endometrial Cancer: Treatment Optimization

Peer Exchange

Kimberly A. Spickes, CNP, discusses how often patients with endometrial cancer have dose reductions or interruptions at her institution, and who is involved in the decision to dose-reduce.

Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer

Patient Profile Presentation: A 76-Year-Old Woman With Advanced Endometrial Cancer

Fertility and Other Treatment Considerations for Patients With Advanced Endometrial Cancer

Currently Available Treatment Modalities in Endometrial Cancer

First-Line Treatments for Patients With Advanced Endometrial Cancer Who Are Unfit for Surgery

Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer

Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer

Treatment Options for Patients with Recurrent Endometrial Cancer

Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events 

Monitoring Patients on Therapy for Recurrent Endometrial Cancer

Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer

Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer

Greatest Unmet Needs for Patients with Endometrial Cancer

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer